Delfarma Spółka z Ograniczoną Odpowiedzialnością (KRS 0000180304, NIP 9471902089) is a Polish company, headquartered in Łódź, Łódzkie voivodeship. DELFARMA operates in: Wholesale of pharmaceutical goods (PKD 46.46.Z). Industry: Wholesale trade. The company has been listed in the National Court Register since November 20, 2003. DELFARMA's most recently reported net revenue was 196.5 M PLN for 2023.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Delfarma
Identity
- Name
- Delfarma Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- November 20, 2003
- Registry status as of
- November 21, 2025
- Latest entry
- July 7, 2025
- Founding act
- 1. UMOWA SPÓŁKI Z 12.09.2003 R., REPERTORIUM A NR 3782/2003, NOTARIUSZ RADOSŁAW KANIECKI, KANCELARIA NOTARIALNA W ŁODZI …
Articles of association history (6)
- September 12, 2003: 1. UMOWA SPÓŁKI Z 12.09.2003 R., REPERTORIUM A NR 3782/2003, NOTARIUSZ RADOSŁAW KANIECKI, KANCELARIA NOTARIALNA W ŁODZI 2. 04.11.2003 R., REPERTORIUM A NR 4737/2003, NOTARIUSZ RADOSŁAW KANIECKI, KANCELARIA NOTARIALNA W ŁODZI - ZMIENIONO § 5
- December 20, 2007: 20.12.2007 R , REP. A NR 4278/2007 , NOTARIUSZ GABRIELA SPECHT ZASTĘPUJĄCA NOTARIUSZ ANNĘ KOPCZYŃSKĄ , KANCELARIA NOTARIALNA W ŁODZI - ZMIENIONO § 2, § 4, § 6, § 9 - § 18 ORAZ DODANO § 19 - § 31.
- May 28, 2008: 28.05.2008 R , NOTARIUSZ ZOFIA KRÓL , KANCELARIA NOTARIALNA W ŁODZI , REP. A NR 3082/2008 - ZMIANA TREŚCI § 22 UST. 7.
- May 31, 2010: 31.05.2010R.,NOTARIUSZ IWONA SZABELSKA,KANCELARIA NOTARIALNA W ŁODZI ,REP.A NR 6522/2010 - ZMIANA § 5
- October 12, 2010: AKT NOTARIALNY Z DNIA 12.10.2010 R. SPORZĄDZONY PRZEZ ASESORA NOTARIALNEGO ANGELIKĘ PRZYBYSZEK ZASTĘPUJĄCĄ NOTARIUSZA RADOSŁAWA KANIECKIEGO, KANCELARIA NOTARIALNA W ŁODZI, REP. A NR 8777/2010, ZMIANA § 22 UST. 1
- 25 STYCZNIA 2012R.ASESOR NOTARIALNY ŁUKASZ DRZAZGA ZASTĘPUJĄCY NOTARIUSZA RADOSŁAWA KANIECKIEGO KANCELARIA NOTARIALNA W ŁODZI REPERTORIUM A NR 656/2012 - W § 20 UST.2 DODANO LITERĘ R
Activities
Main activity
46.46.ZWholesale of pharmaceutical goods
Other activities
Address and contact
- Address
- ŚW. TERESY OD DZIECIĄTKA JEZUS, 111, 91-222, ŁÓDŹ, POLSKA
- Voivodeship
- ŁÓDZKIE
- District
- M. ŁÓDŹ
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-66942-13086-GUREV-30
- Coordinates
- 51.7768, 19.4547approx.
Risk and payment profile - Delfarma
Credibility rating
60.9 / 100
Good credibility
Insolvency risk
Very low
Low threat
Closure risk
1
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
Spółka wykazuje sygnały niestabilności organizacyjnej: częste zmiany w zarządzie. Może to wskazywać na podwyższone ryzyko współpracy.
Shareholder changes
7
7/22 yrs
Board changes
14
14/22 yrs
PKD changes
4
4/22 yrs
Name changes
1
1/22 yrs
Data from 22 years of registry activity.
Credibility history
Payment reliability score from 2018–2023
Current: C (61/100)
Trend: deteriorating (-3.4 pts/year)
Moderate payment credibility - the company is able to meet its obligations, but some indicators warrant caution.
Trade credit limit history
Standard limit from 2018–2023
Current: 13.7 M PLN
Safe: 6.2 M PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Delfarma
Founded
November 20, 2003
22 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
ŁÓDŹ
ŁÓDZKIE
Primary PKD
46.46.Z
Wholesale of pharmaceutical goods
Share capital
250.0 K PLN
500 shares total
Shareholders
2
shareholders
Board
2 people
Sup. board: 3 · Proxies: 3
Filed years
6 years
2018–2023
Registry entries
86
latest: July 7, 2025
Revenue
196.5 M PLN
2023
Net profit
1.3 M PLN
2023
Assets
76.1 M PLN
2023
Equity
22.7 M PLN
2023
EBITDA
N/A
2023
no depreciation data
Valuation
11.4 M PLN
Medium confidence
Companies in the same location
EU Funds
Projects co-financed by the European Union for Delfarma - total value, EU contribution and the company's largest awards.
Projects
1
EU co-financing
31.5 K PLN
Total project value
70.8 K PLN
Eligible spending
31.5 K PLN
Funds
Operational programmes
- Pobrexitowa Rezerwa Dostosowawcza
Largest projects
Top 1 by EU co-financing
| Project | Fund | EU co-financing | Value | Rate | Period |
|---|---|---|---|---|---|
Zapobieganie negatywnych skutków Brexit w fimie Delfarma sp. z o.o. |
Public procurement
Trademarks
LEI Code
Global Legal Entity Identifier (LEI) for Delfarma from the GLEIF database - code, status, BIC, registered address and registration details.
LEI code
259400O4KLMN6T787E07
Legal name
"DELFARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ"
Registry number
0000180304
Jurisdiction
PL
Registered address
ŁÓDŹ ŚW. TERESY OD DZIECIĄTKA JEZUS 11191-222 ŁÓDŹPLHeadquarters
ŁÓDŹ DOSTAWCZA 1793-231 ŁÓDŹPLGLEIF registration
- Registration status
- ISSUED
- First registered
- 2017-10-23
- Last updated
Reviews
Rate business credibility - Delfarma.
No ratings
Related articles
Explainer
Eurocash in 2026: Polish FMCG-wholesale leader and Delikatesy Centrum network, an mWIG40 issuer near Poznań, controlled by Luis Amaral
Eurocash S.A. (KRS 0000213765), headquartered at ul. Wiśniowa 11 in Komorniki near Poznań, is the leader of Poland's FMCG-wholesale distribution and the operator of the 1,500+ Delikatesy Centrum store network. Founded in 1995 by Portuguese entrepreneur Luis Amaral, listed on the WSE since 2005, the company is an mWIG40 constituent. A six-member management board, a five-member supervisory board, chaired by the founder himself.
Explainer
Mercator Medical in 2026: a Kraków-based medical-glove producer with plants in Thailand, an mWIG40 issuer after the COVID meme-stock cycle
Mercator Medical S.A. (KRS 0000036244), headquartered at ul. Modrzejewskiej 30 in Kraków, is a Polish producer and distributor of single-use medical gloves (nitrile and latex) and other disposables. The company controls the full value chain: plants in Thailand (Mercator Medical Thailand) plus Polish and international distribution. In 2020 the share price exploded on pandemic demand (from PLN 10 to over PLN 800), followed by cautious normalisation. Listed on the WSE since 2013. A three-member management board, a five-member supervisory board.
